Suchergebnisse - "Zhang, Ruiguang"

PubPharm (90)

1

Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization

enthalten in: Journal of experimental & clinical cancer research | 2024

von Liu, L. | Wang, J. | Wang, Y. | +7

2

Glycolysis‑related lncRNA may be associated with prognosis and immune activity in grade II‑III glioma

enthalten in: Oncology letters | 2024

von Yang, T. | Zhang, R. | Cui, Z. | +4

3

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor : results from three cancer centers in China

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Yan, H. | Song, L. | Li, Y. | +23

4

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China

enthalten in: Cancer immunology immunotherapy | 2024

von Yan, H. | Song, L. | Li, Y. | +23

5

MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma : a real‑world retrospective study

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Wang, N. | Zhang, Y. | Wu, J. | +6

6

An online survey on public awareness of drug clinical trials in inland cities of northern China

enthalten in: Frontiers in public health | 2024

von Wang, L. | Zhang, R. | Liu, J. | +4

7

MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis : a real-world retrospective study

enthalten in: Journal of cancer research and clinical oncology | 2023

von Wang, N. | Zhu, Y. | Wu, Y. | +5

8

Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI Treatment in ALK-Rearranged Non-Small Cell Lung Cancer

enthalten in: Targeted oncology | 2023

von Zheng, N. | Zhang, Y. | Zeng, Y. | +12

9

Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI Treatment in ALK-Rearranged Non-Small Cell Lung Cancer

enthalten in: Targeted oncology | 2023

von Zheng, N. | Zhang, Y. | Zeng, Y. | +12

10

Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI Treatment in ALK-Rearranged Non-Small Cell Lung Cancer

enthalten in: Targeted oncology | 2023

von Zheng, N. | Zhang, Y. | Zeng, Y. | +12

1
2
3
4
5
6
7
8
9
Nächster »
[9]